Nima Aghdam, MD
Radiation Oncology · Boston, MANPI 1942696752
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,300 of the $28,785 with a category attached, or 70.5%. Accuray Incorporated accounts for 65.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $15,756, 3.4 times the $4,682 reported in 2023. Among radiation oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $639.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Accuray Incorporated$19K
- Bioprotect Medical, Inc.$9K
- Blue Earth Diagnostics$445
- Novartis$104
- Teleflex LLC$30
- Pfizer$27
- plus $50 from 2 others
What the payments were for
- Consulting fees$20,30071%
- Speaking & faculty fees$4,50016%
- Travel & lodging$1,3735%
- Food & beverage$1,3135%
- Education$1,2995%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Accuray Incorporated | 28 | $18,957 |
| Bioprotect Medical, Inc. | 8 | $9,172 |
| Blue Earth Diagnostics | 4 | $445 |
| Novartis | 1 | $104 |
| Teleflex LLC | 1 | $30 |
| Pfizer | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| AstraZeneca | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CyberKnife System$18,957
- BIOPROTECT BALLOON IMPLANT SYSTEM$9,023
- POSLUMA$376
- Tomo Therapy System$157
- PLUVICTO$104
How this compares
$28,785 in reported general payments places this provider in the 95th percentile of 200 radiation oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 271 | $3,969 |
| Solifenacin Succinate | 45 | $3,359 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $537 |
| Finasteride | 12 | $275 |
| Dexamethasone | 12 | $87 |
| Cephalexin | 17 | $30 |
| Pentoxifylline | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Boston
- Peter OrioBoston$1.8M
- Paul NguyenBoston$721K
- Jason EfstathiouBoston$156K
- Jonathan SchoenfeldBoston$53K
- Martin KingBoston$37K
- Raymond MakBoston$36K
- Shannon MacdonaldBoston$33K
- Rachel JimenezBoston$28K
- Theodore HongBoston$24K
- Alice HoBoston$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.